Effects of written action plan adherence on COPD exacerbation recovery.
Identifieur interne : 000529 ( Main/Exploration ); précédent : 000528; suivant : 000530Effects of written action plan adherence on COPD exacerbation recovery.
Auteurs : Erik W M A. Bischoff [Pays-Bas] ; Dina H. Hamd ; Maria Sedeno ; Andrea Benedetti ; Tjard R J. Schermer ; Sarah Bernard ; François Maltais ; Jean BourbeauSource :
- Thorax [ 1468-3296 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antibactériens (administration et posologie), Association de médicaments, Autosoins (), Autosoins (normes), Broncho-pneumopathie chronique obstructive (), Broncho-pneumopathie chronique obstructive (psychologie), Calendrier d'administration des médicaments, Canada, Facteurs temps, Femelle, Glucocorticoïdes (administration et posologie), Humains, Mâle, Observance thérapeutique, Ordonnances médicamenteuses (normes), Planification des soins du patient, Prednisone (usage thérapeutique), Prestations des soins de santé (), Sujet âgé, Éducation du patient comme sujet (), Éducation du patient comme sujet (normes), Études prospectives.
- MESH :
- administration et posologie : Antibactériens, Glucocorticoïdes.
- normes : Autosoins, Ordonnances médicamenteuses, Éducation du patient comme sujet.
- psychologie : Broncho-pneumopathie chronique obstructive.
- usage thérapeutique : Prednisone.
- Adulte d'âge moyen, Association de médicaments, Autosoins, Broncho-pneumopathie chronique obstructive, Calendrier d'administration des médicaments, Canada, Facteurs temps, Femelle, Humains, Mâle, Observance thérapeutique, Planification des soins du patient, Prestations des soins de santé, Sujet âgé, Éducation du patient comme sujet, Études prospectives.
English descriptors
- KwdEn :
- Aged, Anti-Bacterial Agents (administration & dosage), Canada, Delivery of Health Care (statistics & numerical data), Drug Administration Schedule, Drug Prescriptions (standards), Drug Therapy, Combination, Female, Glucocorticoids (administration & dosage), Humans, Male, Middle Aged, Patient Care Planning, Patient Compliance, Patient Education as Topic (methods), Patient Education as Topic (standards), Prednisone (therapeutic use), Prospective Studies, Pulmonary Disease, Chronic Obstructive (psychology), Pulmonary Disease, Chronic Obstructive (therapy), Self Care (methods), Self Care (standards), Time Factors.
- MESH :
- chemical , administration & dosage : Anti-Bacterial Agents, Glucocorticoids.
- methods : Patient Education as Topic, Self Care.
- psychology : Pulmonary Disease, Chronic Obstructive.
- standards : Drug Prescriptions, Patient Education as Topic, Self Care.
- statistics & numerical data : Delivery of Health Care.
- chemical , therapeutic use : Prednisone.
- therapy : Pulmonary Disease, Chronic Obstructive.
- Aged, Canada, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Patient Care Planning, Patient Compliance, Prospective Studies, Time Factors.
Abstract
BACKGROUND
The effects of written action plans on recovery from exacerbations of chronic obstructive pulmonary disease (COPD) have not been well studied. The aims of this study were to assess the effects of adherence to a written action plan on exacerbation recovery time and unscheduled healthcare utilisation and to explore factors associated with action plan adherence.
METHODS
This was a 1-year prospective cohort study embedded in a randomised controlled trial. Exacerbation data were recorded for 252 patients with COPD who received a written action plan for prompt treatment of exacerbations with the instructions to initiate standing prescriptions for both antibiotics and prednisone within 3 days of exacerbation onset. Following the instructions was defined as adherence to the action plan.
RESULTS
From the 288 exacerbations reported by 143 patients, start dates of antibiotics or prednisone were provided in 217 exacerbations reported by 119 patients (53.8% male, mean age 65.4 years, post-bronchodilator forced expiratory volume in 1 s (FEV(1)) 43.9% predicted). In 40.1% of exacerbations, patients adhered to their written action plan. Adherence reduced exacerbation recovery time with statistical (p=0.0001) and clinical (-5.8 days) significance, but did not affect unscheduled healthcare utilisation (OR 0.94, 95% CI 0.49 to 1.83). Factors associated with an increased likelihood of adherence were influenza vaccination, cardiac comorbidity, younger age and lower FEV(1) as percentage predicted.
CONCLUSIONS
This study shows that adherence to a written action plan is associated with a reduction in exacerbation recovery time by prompt treatment. Knowing the factors that are associated with proper and prompt utilisation of an action plan permits healthcare professionals to better focus their self-management support on appropriate patients.
DOI: 10.1136/thx.2009.127621
PubMed: 21037270
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of written action plan adherence on COPD exacerbation recovery.</title><author><name sortKey="Bischoff, Erik W M A" sort="Bischoff, Erik W M A" uniqKey="Bischoff E" first="Erik W M A" last="Bischoff">Erik W M A. Bischoff</name><affiliation wicri:level="3"><nlm:affiliation>Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Hamd, Dina H" sort="Hamd, Dina H" uniqKey="Hamd D" first="Dina H" last="Hamd">Dina H. Hamd</name></author><author><name sortKey="Sedeno, Maria" sort="Sedeno, Maria" uniqKey="Sedeno M" first="Maria" last="Sedeno">Maria Sedeno</name></author><author><name sortKey="Benedetti, Andrea" sort="Benedetti, Andrea" uniqKey="Benedetti A" first="Andrea" last="Benedetti">Andrea Benedetti</name></author><author><name sortKey="Schermer, Tjard R J" sort="Schermer, Tjard R J" uniqKey="Schermer T" first="Tjard R J" last="Schermer">Tjard R J. Schermer</name></author><author><name sortKey="Bernard, Sarah" sort="Bernard, Sarah" uniqKey="Bernard S" first="Sarah" last="Bernard">Sarah Bernard</name></author><author><name sortKey="Maltais, Francois" sort="Maltais, Francois" uniqKey="Maltais F" first="François" last="Maltais">François Maltais</name></author><author><name sortKey="Bourbeau, Jean" sort="Bourbeau, Jean" uniqKey="Bourbeau J" first="Jean" last="Bourbeau">Jean Bourbeau</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21037270</idno><idno type="pmid">21037270</idno><idno type="doi">10.1136/thx.2009.127621</idno><idno type="wicri:Area/Main/Corpus">000588</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000588</idno><idno type="wicri:Area/Main/Curation">000588</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000588</idno><idno type="wicri:Area/Main/Exploration">000588</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effects of written action plan adherence on COPD exacerbation recovery.</title><author><name sortKey="Bischoff, Erik W M A" sort="Bischoff, Erik W M A" uniqKey="Bischoff E" first="Erik W M A" last="Bischoff">Erik W M A. Bischoff</name><affiliation wicri:level="3"><nlm:affiliation>Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Hamd, Dina H" sort="Hamd, Dina H" uniqKey="Hamd D" first="Dina H" last="Hamd">Dina H. Hamd</name></author><author><name sortKey="Sedeno, Maria" sort="Sedeno, Maria" uniqKey="Sedeno M" first="Maria" last="Sedeno">Maria Sedeno</name></author><author><name sortKey="Benedetti, Andrea" sort="Benedetti, Andrea" uniqKey="Benedetti A" first="Andrea" last="Benedetti">Andrea Benedetti</name></author><author><name sortKey="Schermer, Tjard R J" sort="Schermer, Tjard R J" uniqKey="Schermer T" first="Tjard R J" last="Schermer">Tjard R J. Schermer</name></author><author><name sortKey="Bernard, Sarah" sort="Bernard, Sarah" uniqKey="Bernard S" first="Sarah" last="Bernard">Sarah Bernard</name></author><author><name sortKey="Maltais, Francois" sort="Maltais, Francois" uniqKey="Maltais F" first="François" last="Maltais">François Maltais</name></author><author><name sortKey="Bourbeau, Jean" sort="Bourbeau, Jean" uniqKey="Bourbeau J" first="Jean" last="Bourbeau">Jean Bourbeau</name></author></analytic><series><title level="j">Thorax</title><idno type="eISSN">1468-3296</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Anti-Bacterial Agents (administration & dosage)</term><term>Canada</term><term>Delivery of Health Care (statistics & numerical data)</term><term>Drug Administration Schedule</term><term>Drug Prescriptions (standards)</term><term>Drug Therapy, Combination</term><term>Female</term><term>Glucocorticoids (administration & dosage)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Care Planning</term><term>Patient Compliance</term><term>Patient Education as Topic (methods)</term><term>Patient Education as Topic (standards)</term><term>Prednisone (therapeutic use)</term><term>Prospective Studies</term><term>Pulmonary Disease, Chronic Obstructive (psychology)</term><term>Pulmonary Disease, Chronic Obstructive (therapy)</term><term>Self Care (methods)</term><term>Self Care (standards)</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antibactériens (administration et posologie)</term><term>Association de médicaments</term><term>Autosoins ()</term><term>Autosoins (normes)</term><term>Broncho-pneumopathie chronique obstructive ()</term><term>Broncho-pneumopathie chronique obstructive (psychologie)</term><term>Calendrier d'administration des médicaments</term><term>Canada</term><term>Facteurs temps</term><term>Femelle</term><term>Glucocorticoïdes (administration et posologie)</term><term>Humains</term><term>Mâle</term><term>Observance thérapeutique</term><term>Ordonnances médicamenteuses (normes)</term><term>Planification des soins du patient</term><term>Prednisone (usage thérapeutique)</term><term>Prestations des soins de santé ()</term><term>Sujet âgé</term><term>Éducation du patient comme sujet ()</term><term>Éducation du patient comme sujet (normes)</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Glucocorticoids</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term><term>Glucocorticoïdes</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Patient Education as Topic</term><term>Self Care</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Autosoins</term><term>Ordonnances médicamenteuses</term><term>Éducation du patient comme sujet</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Broncho-pneumopathie chronique obstructive</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Drug Prescriptions</term><term>Patient Education as Topic</term><term>Self Care</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Delivery of Health Care</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Prednisone</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Canada</term><term>Drug Administration Schedule</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Care Planning</term><term>Patient Compliance</term><term>Prospective Studies</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association de médicaments</term><term>Autosoins</term><term>Broncho-pneumopathie chronique obstructive</term><term>Calendrier d'administration des médicaments</term><term>Canada</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Observance thérapeutique</term><term>Planification des soins du patient</term><term>Prestations des soins de santé</term><term>Sujet âgé</term><term>Éducation du patient comme sujet</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The effects of written action plans on recovery from exacerbations of chronic obstructive pulmonary disease (COPD) have not been well studied. The aims of this study were to assess the effects of adherence to a written action plan on exacerbation recovery time and unscheduled healthcare utilisation and to explore factors associated with action plan adherence.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>This was a 1-year prospective cohort study embedded in a randomised controlled trial. Exacerbation data were recorded for 252 patients with COPD who received a written action plan for prompt treatment of exacerbations with the instructions to initiate standing prescriptions for both antibiotics and prednisone within 3 days of exacerbation onset. Following the instructions was defined as adherence to the action plan.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>From the 288 exacerbations reported by 143 patients, start dates of antibiotics or prednisone were provided in 217 exacerbations reported by 119 patients (53.8% male, mean age 65.4 years, post-bronchodilator forced expiratory volume in 1 s (FEV(1)) 43.9% predicted). In 40.1% of exacerbations, patients adhered to their written action plan. Adherence reduced exacerbation recovery time with statistical (p=0.0001) and clinical (-5.8 days) significance, but did not affect unscheduled healthcare utilisation (OR 0.94, 95% CI 0.49 to 1.83). Factors associated with an increased likelihood of adherence were influenza vaccination, cardiac comorbidity, younger age and lower FEV(1) as percentage predicted.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>This study shows that adherence to a written action plan is associated with a reduction in exacerbation recovery time by prompt treatment. Knowing the factors that are associated with proper and prompt utilisation of an action plan permits healthcare professionals to better focus their self-management support on appropriate patients.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21037270</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3296</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Thorax</Title><ISOAbbreviation>Thorax</ISOAbbreviation></Journal><ArticleTitle>Effects of written action plan adherence on COPD exacerbation recovery.</ArticleTitle><Pagination><MedlinePgn>26-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/thx.2009.127621</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effects of written action plans on recovery from exacerbations of chronic obstructive pulmonary disease (COPD) have not been well studied. The aims of this study were to assess the effects of adherence to a written action plan on exacerbation recovery time and unscheduled healthcare utilisation and to explore factors associated with action plan adherence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a 1-year prospective cohort study embedded in a randomised controlled trial. Exacerbation data were recorded for 252 patients with COPD who received a written action plan for prompt treatment of exacerbations with the instructions to initiate standing prescriptions for both antibiotics and prednisone within 3 days of exacerbation onset. Following the instructions was defined as adherence to the action plan.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From the 288 exacerbations reported by 143 patients, start dates of antibiotics or prednisone were provided in 217 exacerbations reported by 119 patients (53.8% male, mean age 65.4 years, post-bronchodilator forced expiratory volume in 1 s (FEV(1)) 43.9% predicted). In 40.1% of exacerbations, patients adhered to their written action plan. Adherence reduced exacerbation recovery time with statistical (p=0.0001) and clinical (-5.8 days) significance, but did not affect unscheduled healthcare utilisation (OR 0.94, 95% CI 0.49 to 1.83). Factors associated with an increased likelihood of adherence were influenza vaccination, cardiac comorbidity, younger age and lower FEV(1) as percentage predicted.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows that adherence to a written action plan is associated with a reduction in exacerbation recovery time by prompt treatment. Knowing the factors that are associated with proper and prompt utilisation of an action plan permits healthcare professionals to better focus their self-management support on appropriate patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bischoff</LastName><ForeName>Erik W M A</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamd</LastName><ForeName>Dina H</ForeName><Initials>DH</Initials></Author><Author ValidYN="Y"><LastName>Sedeno</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Schermer</LastName><ForeName>Tjard R J</ForeName><Initials>TR</Initials></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Maltais</LastName><ForeName>François</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Bourbeau</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MCT-63162</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Thorax</MedlineTA><NlmUniqueID>0417353</NlmUniqueID><ISSNLinking>0040-6376</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Thorax. 2011 Nov;66(11):935-6</RefSource><PMID Version="1">21813621</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010347" MajorTopicYN="Y">Patient Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21037270</ArticleId><ArticleId IdType="pii">thx.2009.127621</ArticleId><ArticleId IdType="doi">10.1136/thx.2009.127621</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country><region><li>Gueldre</li></region><settlement><li>Nimègue</li></settlement></list><tree><noCountry><name sortKey="Benedetti, Andrea" sort="Benedetti, Andrea" uniqKey="Benedetti A" first="Andrea" last="Benedetti">Andrea Benedetti</name><name sortKey="Bernard, Sarah" sort="Bernard, Sarah" uniqKey="Bernard S" first="Sarah" last="Bernard">Sarah Bernard</name><name sortKey="Bourbeau, Jean" sort="Bourbeau, Jean" uniqKey="Bourbeau J" first="Jean" last="Bourbeau">Jean Bourbeau</name><name sortKey="Hamd, Dina H" sort="Hamd, Dina H" uniqKey="Hamd D" first="Dina H" last="Hamd">Dina H. Hamd</name><name sortKey="Maltais, Francois" sort="Maltais, Francois" uniqKey="Maltais F" first="François" last="Maltais">François Maltais</name><name sortKey="Schermer, Tjard R J" sort="Schermer, Tjard R J" uniqKey="Schermer T" first="Tjard R J" last="Schermer">Tjard R J. Schermer</name><name sortKey="Sedeno, Maria" sort="Sedeno, Maria" uniqKey="Sedeno M" first="Maria" last="Sedeno">Maria Sedeno</name></noCountry><country name="Pays-Bas"><region name="Gueldre"><name sortKey="Bischoff, Erik W M A" sort="Bischoff, Erik W M A" uniqKey="Bischoff E" first="Erik W M A" last="Bischoff">Erik W M A. Bischoff</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000529 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000529 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21037270
|texte= Effects of written action plan adherence on COPD exacerbation recovery.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21037270" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |